
iSERA Lifesciences Ltd is Rated Hold
2026-10-31 10:10:03iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 Sep 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
iSERA Lifesciences Ltd is Rated Hold by MarketsMOJO
2026-09-28 10:10:05iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreiSERA Lifesciences Ltd’s Stagnant Week Masks 4.97% Surge and Valuation Concerns
2026-09-20 14:00:06Key Events This Week 15 Sep: Stock steady at Rs.143.90 despite Sensex decline 16 Sep: No price change, minimal volume 17 Sep: New 52-week high at Rs.151.05 (+4.97%) 18 Sep: Sharp correction to Rs.143.90 (-4.73%) Week OpenRs.143.90 Week CloseRs.143.90+0.00%</...
Read More
Broad-Based Technical Strength Lifts iSERA Lifesciences Ltd to 52-Week High of Rs 151.05
2026-09-17 13:40:08From a low of Rs 5.36 to a remarkable Rs 151.05, iSERA Lifesciences Ltd has surged over 2,600% in the past year, culminating in a fresh 52-week high on 17 Jun 2026. This extraordinary price momentum stands out sharply against the broader market backdrop, where the Sensex has declined by 10.12% over the same period.
Read More
iSERA Lifesciences Ltd Valuation Shifts Signal Price Attractiveness Concerns
2026-09-17 08:00:13iSERA Lifesciences Ltd has witnessed a dramatic shift in its valuation parameters, moving from a non-qualifying valuation status to being classified as very expensive. Despite this, the stock has delivered extraordinary returns year-to-date and over the past year, significantly outperforming the Sensex. This article analyses the recent valuation changes, compares them with peer averages, and assesses the implications for investors.
Read More
iSERA Lifesciences Ltd is Rated Hold
2026-09-16 10:10:03iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 September 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read MoreRevision In The Corporate Announcement Under Regulation 30 Made On 12/11/2026 Pursuant To The Directions Received From BSE Via Mail
14-Nov-2026 | Source : BSEDisclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 - Administrative Warning Letter received from the Securities and Exchange Board of India (the SEBI).
Dissemination Of Warning Letter Of SEBI
12-Nov-2026 | Source : BSEDissemination of Warning Letter of SEBI
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSEIntimation for Newspaper Publication of Un-Audited Financial Results for the quarter and half year ended 30th September 2026 pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Corporate Actions
No Upcoming Board Meetings
iSERA Lifesciences Ltd has declared 5% dividend, ex-date: 20 Sep 13
No Splits history available
No Bonus history available
iSERA Lifesciences Ltd has announced 25:1 rights issue, ex-date: 24 Oct 25